Pharmaceutical
Manufacture Where the FDA Already Trusts the Infrastructure
Pharmaceutical manufacturing carries the highest regulatory stakes of any sector, and the highest cost of getting it wrong. Puerto Rico isn't an emerging option it's a mature pharmaceutical manufacturing hub with decades of FDA inspection history, cGMP-ready infrastructure, and a specialized labor pool most jurisdictions can't replicate.
For European pharmaceutical companies, this converts a high-risk market entry into a controlled, de-risked operational decision.
Puerto Rico Advantages in Pharmaceutical Manufacturing:
- Established cGMP Ecosystem — Infrastructure and inspection history already validated by global Pharma leaders
- US Jurisdiction Means US Market Access — Direct entry without the compliance lag of international trade
- Deep Pharma Talent Pool — Technicians, engineers, and QA specialists trained within an FDA-regulated environment
- Act 60 Fiscal Advantages — Substantial tax relief that strengthens long-term margins on regulated production
